Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.

Détails

Ressource 1Télécharger: 35086840.pdf (1727.40 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_60B78D05C320
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.
Périodique
The European respiratory journal
Auteur⸱e⸱s
Evangelou K., Veroutis D., Paschalaki K., Foukas P.G., Lagopati N., Dimitriou M., Papaspyropoulos A., Konda B., Hazapis O., Polyzou A., Havaki S., Kotsinas A., Kittas C., Tzioufas A.G., de Leval L., Vassilakos D., Tsiodras S., Stripp B.R., Papantonis A., Blandino G., Karakasiliotis I., Barnes P.J., Gorgoulis V.G.
ISSN
1399-3003 (Electronic)
ISSN-L
0903-1936
Statut éditorial
Publié
Date de publication
08/2022
Peer-reviewed
Oui
Volume
60
Numéro
2
Pages
2102951
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of the respiratory system can progress to a multisystemic disease with aberrant inflammatory response. Cellular senescence promotes chronic inflammation, named senescence-associated secretory phenotype (SASP). We investigated whether coronavirus disease 2019 (COVID-19) is associated with cellular senescence and SASP.
Autopsy lung tissue samples from 11 COVID-19 patients and 43 age-matched non-COVID-19 controls with similar comorbidities were analysed by immunohistochemistry for SARS-CoV-2, markers of senescence and key SASP cytokines. Virally induced senescence was functionally recapitulated in vitro, by infecting epithelial Vero-E6 cells and a three-dimensional alveosphere system of alveolar type 2 (AT2) cells with SARS-CoV-2 strains isolated from COVID-19 patients.
SARS-CoV-2 was detected by immunocytochemistry and electron microscopy predominantly in AT2 cells. Infected AT2 cells expressed angiotensin-converting enzyme 2 and exhibited increased senescence (p16 <sup>INK4A</sup> and SenTraGor positivity) and interleukin (IL)-1β and IL-6 expression. In vitro, infection of Vero-E6 cells with SARS-CoV-2 induced senescence (SenTraGor), DNA damage (γ-H2AX) and increased cytokine (IL-1β, IL-6, CXCL8) and apolipoprotein B mRNA-editing (APOBEC) enzyme expression. Next-generation sequencing analysis of progenies obtained from infected/senescent Vero-E6 cells demonstrated APOBEC-mediated SARS-CoV-2 mutations. Dissemination of the SARS-CoV-2-infection and senescence was confirmed in extrapulmonary sites (kidney and liver) of a COVID-19 patient.
We demonstrate that in severe COVID-19, AT2 cells infected by SARS-CoV-2 exhibit senescence and a proinflammatory phenotype. In vitro, SARS-CoV-2 infection induces senescence and inflammation. Importantly, infected senescent cells may act as a source of SARS-CoV-2 mutagenesis mediated by APOBEC enzymes. Therefore, SARS-CoV-2-induced senescence may be an important molecular mechanism of severe COVID-19, disease persistence and mutagenesis.
Mots-clé
COVID-19, Cellular Senescence, Cytokines/metabolism, Humans, Inflammation, Interleukin-6, Lung/metabolism, Mutagenesis, Phenotype, SARS-CoV-2
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/01/2022 8:02
Dernière modification de la notice
14/12/2022 6:54
Données d'usage